CEO message

CEO message

Enrich the world with smiles
Peptide-based drugs have been solving medical needs for variety of diseases and will increase importance and demand due to rising prevalence of chronic diseases in the foreseeable future. Availability of rapid-acting and efficient drugs and introduction of innovative drug manufacturing processes with high quality, low cost and environment-friendly are key factors for meeting the requirements from society.

Jitsubo founded in 2005 by inventor of Molecular Hiving Technology, Prof. Kazuhiro Chiba (co-founder) and others, has been broadening and refining the technology base and now we are ready to offer high quality peptide APIs manufactured by this innovative, low cost and environment-friendly technology.

We will keep broadening our technology base working with our superb technology network of academia and industry in medium molecular drugs and through our effort, we sincerely hope that patients will be filled with smiles worldwide.
President
CEO
Kazuaki Kanai, Ph.D.
PAGE TOP